NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-192-2023-0-PC-01 Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis PCT PCT PCT/EP2022/079286 Expired
NIDDK E-108-2020-0-EP-03 Thyclotides EP National Stage 21723830.2 Pending
NCI E-192-2023-0-TW-01 Neutrophil Elastase Inhibitors for Use in the Treatment of Fibrosis TW ORD 111139905 Pending
NCI E-102-2020-0-EP-06 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY EP National Stage 21718376.3 Pending
OD E-120-2021-0-PCT-02 PREDICTION OF TRANSFORMATIVE BREAKTHROUGHS IN RESEARCH PCT PCT PCT/US2022/047099 Expired
NCI E-244-2015-0-AU-21 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use AU DIV 2022256143 Pending
NIAID E-131-2019-0-US-06 RECOMBINANT HUMAN METAPNEUMOVIRUS F PROTEINS AND THEIR USE US National Stage 17/919,733 Pending
NCI E-061-2020-0-KR-08 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY KR National Stage 2022-7036214 Pending
NCI E-102-2020-0-KR-08 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY KR National Stage 2022-7036226 Pending
NIAID E-080-2013-0-EP-11 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization EP DIV 22201434.2 Pending
NIDDK E-108-2020-0-US-04 Thyclotides US National Stage 17/918,725 Pending
NCI E-003-2022-0-PCT-02 AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING PCT PCT PCT/US2022/046406 Expired
NCI E-055-2017-0-CN-13 Combination Therapy of Immunotoxin and Checkpoint Inhibitor CN DIV 2022-11-24 Pending
NCI E-061-2020-0-EP-06 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY EP National Stage 21718712.9 Pending
NCI E-075-2020-0-EP-05 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES EP National Stage 21715394.9 Pending
NIBIB E-168-2021-2-PCT-01 Systems and Methods for Three-Dimensional Structured Illumination Microscopy With Isotropic Spatial
Resolution 		PCT PCT COMB PCT/US2022/077763 Pending
NIA E-207-2021-0-PCT-02 COMPOUNDS AND MOLECULAR TARGETS FOR TREATING AND/OR PREVENTING ALZHEIMER'S DISEASE PCT PCT PCT/US2022/046018 Expired
NIAID E-228-2016-1-AU-15 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof AU DIV 2022246465 Pending
NCI E-040-2012-0-US-72 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/938,535 11827889 Issued PDF
NCI E-040-2012-0-US-71 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/938,529 11773396 Issued PDF
NIAID E-160-2021-0-PCT-02 AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 PCT PCT PCT/US2022/077634 Expired
NIAID E-178-2014-2-US-11 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE US CON 17/937,719 Pending
NHLBI E-188-2021-0-PCT-02 ANTI-CMPL DIVALENT SCFV AND USES THEREOF PCT PCT PCT/US22/77326 Expired
NIBIB E-006-2020-0-US-03 SYSTEMS AND METHODS FOR MULTIVIEW SUPER-RESOLUTION MICROSCOPY US National Stage 17/995,271 Pending
NCI E-055-2017-0-HK-12 Combination Therapy of Immunotoxin and Checkpoint Inhibitor HK EP 42022061535.5 Pending
NICHD E-185-2021-0-PCT-02 CYCLIC PEPTIDES AS NON-HORMONAL MALE CONTRACEPTIVE AGENTS AND METHODS OF USE THEREOF PCT PCT PCT/US2022/077278 Expired
NIAAA E-282-2012-0-US-17 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US CON 17/956,313 Abandoned
NCI E-230-2012-0-US-82 T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3 US CON 17/936,006 Pending
NIAID E-081-2013-4-KR-23 Prefusion RSV F Proteins And Their Use KR DIV 10-2022-7033808 Pending
NCI E-061-2020-0-AU-03 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY AU National Stage 2021237717 Pending
NCI E-494-2013-0-EP-30 Methods of Preparing Anti-human Papillomavirus Antigen T Cells EP DIV 22197914.9 Pending
NCI E-103-2019-0-HK-16 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE HK CN 62022061195.3 Issued
NIAID E-236-2018-0-US-01 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof US DIV 17/952,308 Pending
NIAID E-097-2020-0-US-02 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE US National Stage 17/914,027 Pending
NCI E-088-2020-0-EP-07 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION EP National Stage 21 712 694.5 Pending
NCI E-102-2020-0-AU-03 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY AU National Stage 2021239379 Pending
NCI E-088-2020-0-KR-10 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION KR National Stage 2022-7033222 Pending
NCI E-165-2021-0-PCT-02 FIBP Knockout In T Cells Amplifies Antitumor Activity By Limiting Cholesterol Metabolism, Suggesting A Potentiator Of Adoptive Cell Therapy PCT PCT PCT/US2022/076809 Expired
NCI E-059-2013-0-AU-24 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor AU DIV 2022235535 Pending
NCI E-075-2020-0-AU-03 SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES AU National Stage 2021236049 Pending
NLM E-111-2016-7-EP-10 Novel CRISPR Enzymes And Systems EP DIV 22196333.3 Pending
NCI E-061-2020-0-IL-10 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY IL National Stage 296629 Pending
NCI E-102-2020-0-IL-10 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY IL National Stage 296608 Pending
NIAID E-086-2018-3-US-05 Zika Viral Antigen Constructs US CON 17/946,383 Pending
NCI E-061-2020-0-US-09 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US National Stage 17/912,315 Pending
NCI E-102-2020-0-US-09 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BYSINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US National Stage 17/906,524 Pending
NIAID E-131-2020-7-IN-21 Anti-Coronavirus Antibodies And Methods Of Use IN National Stage 202217053137 Pending
NCI E-061-2020-0-JP-07 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY JP National Stage 2022-556459 Pending
NCI E-102-2020-0-JP-07 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY JP National Stage 2022-556460 Pending
NCI E-176-2014-0-KR-66 Anti-Human Papillomavirus 16 E7 T Cell Receptors KR DIV 2022-7032043 Issued